Ionis Pharmaceuticals (IONS) reaffirms guidance

Ionis Pharmaceuticals (NASDAQ: IONS) is reaffirming its previously announced financial guidance for the fiscal year ending December 31, 2026, which remains unchanged from the financial guidance the Company provided on April 29, 2026 in its first quarter 2026 earnings release.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M